Bradley Corr, MD, of the University of Colorado Anschutz Cancer Center, praised near‑perfect disease control seen with the bispecific antibody cadonilimab plus chemotherapy in advanced endometrial cancer.
CU Anschutz
Anschutz Cancer Pavilion
1665 North Aurora Court
2004
Aurora, CO 80045